Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavitian, Suzanne, Peron, Jean-Marie, Huguet, Françoise, Kamar, Nassim, Abravanel, Florence, Beyne-Rauzy, Odile, Oberic, Lucie, Faguer, Stanislas, Alric, Laurent, Roussel, Murielle, Gaudin, Clément, Ysebaert, Loïc, Huynh, Anne, Recher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2015
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517705/
https://www.ncbi.nlm.nih.gov/pubmed/26197210
http://dx.doi.org/10.3201/eid2108.150199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517705/
https://www.ncbi.nlm.nih.gov/pubmed/26197210
http://dx.doi.org/10.3201/eid2108.150199

Ejemplares similares